Live News EQUITY FLASH L impact Oct 30, 2026, 08:04 AM UTC Samsung Bioepis Seeks U.S. Approval for Keytruda Biosimilar Samsung Bioepis has applied for U.S. approval of a Keytruda biosimilar. SquawkNews Desk